Trial Profile
Clinical Trials Insight: 700013616
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 26 May 2008
Price :
$35
*
At a glance
- Drugs LX 6171 (Primary)
- Indications Cognition disorders; Dementia; Schizophrenia
- Focus Adverse reactions
- Sponsors Lexicon Pharmaceuticals
- 15 Apr 2008 Preliminary data reported at the American Academy of Neurology 2008
- 08 Sep 2006 Status change
- 03 Jul 2006 New trial record.